Dementia and Alzheimer Disease

May 17, 2022

The blood test from Diadem SpA, which quantifies the AZ 284 peptide as readout of U-p53AZ, showed a significantly higher AUC in both time-independent and time-dependent prognostic analyses than gold standard testing.

May 17, 2022

The importance of addressing disorders of the brain cannot be overstated, and doing so will be essential to our generation and generations to come.

May 16, 2022

Here's what is coming soon to NeurologyLive®.

May 15, 2022

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is sleep disorders.

May 14, 2022

Neurology News Network for the week ending May 14, 2022. [WATCH TIME: 4 minutes]

May 13, 2022

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 13, 2022.

May 13, 2022

A Harris Poll conducted by Quest Diagnostics suggests that more than 65% of US physicians believe the Alzheimer disease field is on the cusp of a breakthrough, with more than 80% noting that earlier evaluation with blood testing may help improve therapeutic approaches.

May 10, 2022

The biologics license application includes data from the pivotal phase 2b proof-of-concept trial, its open-label extension, and the ongoing phase 3 Clarity AD study, which includes almost 1800 participants.

May 09, 2022

Baseline cognition and function were highly correlated in those with mixed Alzheimer and Lewy body dementia pathologies, but not in pure Alzheimer disease nor pure dementia with Lewy bodies.

May 09, 2022

Here's what is coming soon to NeurologyLive®.